Overview

A Pilot Clinical Trial Of Memantine for Essential Tremor

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to obtain information on whether or not the medication Memantine reduces tremor in persons with essential tremor and is well-tolerated.
Phase:
Phase 4
Details
Lead Sponsor:
VA Greater Los Angeles Healthcare System
Collaborators:
Forest Laboratories
Ralph M. Parsons Foundation
Treatments:
Memantine